| Name | Relationship | Holdings Value | Past Year Net Change | Change % | Report Date |
|---|---|---|---|---|---|
| Bay Shore Trust | 10%+ Owner | $20.4M | Nov 21, 2024 | ||
| Christopher Chapman | CEO & Chairman, Director | $6.05M | Feb 8, 2024 | ||
| Mira Pharmaceuticals, Inc. | 10%+ Owner | $4.82M | Sep 29, 2025 | ||
| Craig Eagle | Director | $3.02M | Feb 8, 2024 | ||
| Nathen Fuentes | Chief Financial Officer | $627K | Feb 8, 2024 | ||
| Bradley Kroenig | Director | $302K | Feb 8, 2024 | ||
| Talhia Tuck | Director | $302K | Feb 8, 2024 | ||
| Hugh McColl III | Director | $302K | Feb 8, 2024 | ||
| Erez Aminov | CEO and Chairman, Director | $184K | May 28, 2025 | ||
| Michelle Yanez | Chief Financial Officer | $151K | Aug 27, 2024 | ||
| Matthew Pratt Whalen | Director | Aug 27, 2024 | |||
| Matthew Paul Del Giudice | Director | Aug 27, 2024 | |||
| Edward MacPherson | Director | Aug 27, 2024 | |||
| Christos Nicholoudis | General Counsel, Director | Feb 8, 2024 | |||
| Alan Weichselbaum | Chief Financial Officer | May 15, 2025 | |||
| Michael Jerman | Director | Aug 27, 2024 |
| Insider | Symbol | Class | Transaction | % | Value $ | * Price $ | Shares | Shares Owned | Date | Ownership |
|---|